Skip to content

4Accepted Mar 18, 9:15 PM ET

Bausch Christoph Lawrence 4

SABSSAB Biotherapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

9:15 PM

Mar 18, 2022

Filed

Mar 18, 2022

Documents

1

Size

5.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.